Medicare Enrolled
Dr. John Chip Reed, M.D.
Endocrinology · Roswell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reed
Dr. John Chip Reed is an endocrinology specialist in Roswell, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reed performed 2,452 Medicare services across 1,517 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reed received a total of $33,253 from 75 pharmaceutical and/or device companies across 1172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in GA
$33,253 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,452
Medicare services
Top 24% in GA for endocrinology
1,517
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,281 | $90 | $342 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
511 | $26 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $62 | $241 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
130 | $38 | $325 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
120 | $78 | $350 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
54 | $18 | $61 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $39 | $149 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $95 | $269 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
12 | $12 | $122 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,253
Total received (2018-2024)
Avg $4,750/year across 7 years
Top 11% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,709 (71.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,544 (28.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,217
2023
$3,106
2022
$3,086
2021
$12,416
2020
$552
2019
$5,469
2018
$6,408
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$346
Novo Nordisk Inc
$299
Xeris Pharmaceuticals, Inc.
$214
SANOFI-AVENTIS U.S. LLC
$187
Abbott Laboratories
$133
BETA BIONICS, INC.
$125
Amgen Inc.
$123
Insulet Corporation
$108
Tandem Diabetes Care, Inc.
$107
CeQur Corporation
$93
Embecta Corp.
$61
Esperion Therapeutics, Inc.
$59
Corcept Therapeutics
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Radius Health, Inc.
$32
RECORDATI_RARE_DISEASES_INC.
$30
ABBVIE INC.
$27
Amphastar Pharmaceuticals, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$23
AstraZeneca Pharmaceuticals LP
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Ascensia Diabetes Care Us Inc.
$20
Astellas Pharma US Inc
$16
IBSA Pharma Inc.
$16
Exact Sciences Corporation
$15
Acella Pharmaceuticals, LLC
$15
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
Tandem Diabetes Care, Inc.
$10,037
Novo Nordisk AS
$4,610
Novo Nordisk Inc
$2,451
Lilly USA, LLC
$1,770
SANOFI-AVENTIS U.S. LLC
$1,464
Amgen Inc.
$1,246
Eli Lilly and Company
$1,235
Insulet Corporation
$954
Abbott Laboratories
$826
Xeris Pharmaceuticals, Inc.
$597
Boehringer Ingelheim Pharmaceuticals, Inc.
$575
Corcept Therapeutics
$470
Radius Health, Inc.
$414
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$360
Dexcom, Inc.
$351
Novartis Pharmaceuticals Corporation
$320
Janssen Pharmaceuticals, Inc
$271
IBSA Pharma Inc.
$271
Amarin Pharma Inc.
$237
Horizon Therapeutics plc
$231
Esperion Therapeutics, Inc.
$215
AbbVie Inc.
$213
Medtronic, Inc.
$213
MEDELA LLC
$212
Antares Pharma, Inc.
$185
CeQur Corporation
$175
AstraZeneca Pharmaceuticals LP
$172
Shire North American Group Inc
$171
Zealand Pharma US, Inc.
$169
PFIZER INC.
$169
Bayer HealthCare Pharmaceuticals Inc.
$167
Amneal Pharmaceuticals LLC
$163
MannKind Corporation
$149
Alexion Pharmaceuticals, Inc.
$142
Merck Sharp & Dohme Corporation
$141
BETA BIONICS, INC.
$125
AbbVie, Inc.
$124
Eisai Inc.
$111
Medtronic MiniMed, Inc.
$110
Kowa Pharmaceuticals America, Inc.
$99
ABBVIE INC.
$91
Mannkind Corporation
$78
Becton, Dickinson and Company
$76
Horizon Pharma plc
$72
Bayer Healthcare Pharmaceuticals Inc.
$70
Ultragenyx Pharmaceutical Inc.
$65
Embecta Corp.
$61
DEXCOM, INC.
$61
Supernus Pharmaceuticals, Inc.
$58
RECORDATI_RARE_DISEASES_INC.
$56
Currax Pharmaceuticals LLC
$52
VIVUS LLC
$49
Ipsen Biopharmaceuticals, Inc
$46
Takeda Pharmaceuticals U.S.A., Inc.
$42
Endo Pharmaceuticals Inc.
$33
NESTLE HEALTHCARE NUTRITION INC.
$32
Companion Medical, Inc.
$32
Nalpropion Pharmaceuticals LLC
$31
Acella Pharmaceuticals, LLC
$30
Amphastar Pharmaceuticals, Inc.
$24
Orexigen Therapeutics, Inc.
$24
VIVUS, Inc.
$23
Nalpropion Pharmaceuticals, Inc.
$23
EISAI INC.
$22
Acerus Pharmaceuticals Corporation
$21
Ascensia Diabetes Care Us Inc.
$20
Valeritas, Inc.
$19
Bigfoot Biomedical Inc
$18
Allergan Inc.
$18
Intuity Medical Inc
$18
Astellas Pharma US Inc
$16
Exact Sciences Corporation
$15
Azurity Pharmaceuticals, Inc.
$15
Amryt Pharma Holdings Ltd
$14
Lexicon Pharmaceuticals, Inc.
$11
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AVEED · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CHANTIX · CONTRAVE · CRYSViTA · CYCLOSET · CeQur Simplicity · Cologuard Collection Kit · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMATROPE · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LYRICA · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · NP Thyroid 60 · Natesto · Omnipod · Ozempic · PRALUENT · PREMARIN · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QULIPTA · Qsymia · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOTAGLIFLOZIN · STIOLTO RESPIMAT · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TESTOPEL · TLANDO · TOUJEO · TRULICITY · TZIELD · Tirosint · Trintellix · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
113
Per 100K population
10.6
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reed is a clinical cardiology specialist, with above-average Medicare volume (top 24% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Reed performed 1,281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reed receive payments from pharmaceutical companies?
Yes. Dr. Reed received a total of $33,253 from 75 companies across 1,172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reed's costs compare to other endocrinologists in Roswell?
Dr. Reed's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Roswell
Browse endocrinologists in Roswell ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Tandem Diabetes Care, Inc. Payments to Doctors
See all physicians who received payments from Tandem Diabetes Care, Inc.
By company
Novo Nordisk AS Payments to Doctors
See all physicians who received payments from Novo Nordisk AS.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology